Skip to main content

Find Clinical Trials

Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

NCT00531284

Conditions: Adnexal Diseases, Blood Protein Disorders, Bronchial Neoplasms, +47 more
Locations: Pinnacle Oncology Scottsdale, Arizona, United States

Tower Cancer Research Foundation Beverly Hills, California, United States

Northwestern University Chicago, Illinois, United States

University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization

NCT02287701

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: NYU Langone Medical Center New York, United States

View Trial Details

Completed

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

NCT00253708

Conditions: Adenocarcinoma, Adnexal Diseases, Behavior, +77 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

An Educational Intervention for Patients With Bladder Cancer

NCT01915121

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

James J. Peters VA Medical Center The Bronx, New York, United States

View Trial Details

Completed

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

NCT02080650

Conditions: Adenocarcinoma, Advanced MET Amplified Solid Tumor, Bladder Cancer, +51 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy

NCT02039310

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers

NCT01528774

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +42 more
Locations: Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States

View Trial Details

Completed

Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer

NCT01687244

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Not specified

View Trial Details

Completed

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

NCT00335556

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +31 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

University of Alabama at Birmingham Birmingham, Alabama, United States

University of South Alabama Mobile, Alabama, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

View all 187 locations

View Trial Details

Completed

Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib

NCT01514448

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Novartis Investigative Site Chemnitz, Germany

Novartis Investigative Site Dresden, Germany

Novartis Investigative Site Hanover, Germany

Novartis Investigative Site Hof, Germany

View all 13 locations

View Trial Details